ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 720616 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 720616; 2) Community: the network communities that were significantly associated with the response to NSC 720616; 3) Molecule: the relationships between components within communities and NSC 720616; 4) MDR: the compounds that were significantly associated with the NSC 720616.

NSC Compound Enrichment Correlation
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0454469012959173 0.20843231
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0454469012959173 0.11584361
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0454469012959173 -0.077984683
NSC 363812 Tetraplatin 0.0454469012959173 -0.043187323
NSC 37168 Acco Naphthol AS-BS 0.0454469012959173 -0.16941929
NSC 374028 Camptothecin Derivative 0.0454469012959173 0.18514826
NSC 38086 Null 0.0454469012959173 -0.31003318
NSC 38643 Lenamycin 0.0454469012959173 -0.054199257
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0454469012959173 0.10189994
NSC 640499 2,2':6',2"-Terpyridine, 4'-[4-(2-hydroxyethoxy)phenyl]- 0.0454469012959173 0.24140555
Total:45  Current:36    [First] [Prev] [Next] [Last]